Trials / Completed
CompletedNCT02979509
Evaluation of Diagnostic Yield of EUS-Guided Tissue Sampling
Multi-center Prospective Evaluation of the Diagnostic Yield of Endoscopic Ultrasound-Guided Tissue Sampling
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 54 (actual)
- Sponsor
- University of Florida · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Accepted
Summary
All patients will receive standard medical care and no experimental interventions will be performed. Endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) is a well-established procedure commonly used for the investigation of lesions within or adjacent to the gastrointestinal (GI) lumen (i.e. pancreas, liver, mediastinal masses, left adrenal gland, lymph nodes, and subepithelial lesions). EUS-guided tissue sampling has been commonly performed with different size and types of aspiration and core biopsy needles.
Detailed description
Endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) is a well-established procedure commonly used for the investigation of lesions within or adjacent to the gastrointestinal (GI) lumen (i.e. pancreas, liver, mediastinal masses, left adrenal gland, lymph nodes, and subepithelial lesions). EUS-guided tissue sampling has been commonly performed with different size and types of aspiration and core biopsy needles. More recently, a novel through-the-needle microforceps has been introduced. The MorayTM microforceps fits through a 19-gauge FNA needle and allows targeted tissue sampling under EUS visualization. Aim - To prospectively evaluate the safety and diagnostic yield of the through-the-needle microforceps for pancreatic and non-pancreatic solid, cystic and mixed solid/cystic lesions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Endoscopic ultrasound- (EUS) guided tissue sampling | EUS- guided tissue sampling of solid and/or cystic pancreatic and non-pancreatic lesions as part of their medical care. |
Timeline
- Start date
- 2016-06-01
- Primary completion
- 2019-08-30
- Completion
- 2019-08-30
- First posted
- 2016-12-01
- Last updated
- 2020-01-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02979509. Inclusion in this directory is not an endorsement.